Not Signed In - ADVENTRX To Present Thiovir Preclinical Data At The 20th International Conference On Antiviral Research
Tue, 13 Feb 2007 08:00 AM EST
... ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical company developing anticancer and antiviral therapies, announced today that data from preclinical studies of Thiovir(TM), a drug candidate in a new class of reverse transcriptase inhibitors (RTIs), will be presented at the 20th International Conference on Antiviral Research (ICAR) in Palm Springs, April 30 - May 4 2007. [click link for full article] ...
Related Topics
- Data Analysis
- National Data
- Data & Statistics
- International Health
- Chemical Safety
- Research
- Child Abuse And Neglect
- Logging
- Understanding Medical Research
- Animal Research
- Stem Cell Research
- Antiviral Agents
- Mining
- International Centers for Tropical Disease Research
- Alzheimer's Disease
- Dysphagia
- Health Services Research
- Metabolic Disorders
- Migration
- Psychopharmacology
email this page
print this page
bookmark this page
feedback on this page
